194 related articles for article (PubMed ID: 20298210)
1. Reversibility of functional deficits in experimental models of Rett syndrome.
Cobb S; Guy J; Bird A
Biochem Soc Trans; 2010 Apr; 38(2):498-506. PubMed ID: 20298210
[TBL] [Abstract][Full Text] [Related]
2. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
Gadalla KK; Bailey ME; Cobb SR
Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
[TBL] [Abstract][Full Text] [Related]
3. Rett syndrome and MeCP2.
Liyanage VR; Rastegar M
Neuromolecular Med; 2014 Jun; 16(2):231-64. PubMed ID: 24615633
[TBL] [Abstract][Full Text] [Related]
4. Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome.
Matagne V; Borloz E; Ehinger Y; Saidi L; Villard L; Roux JC
Neurobiol Dis; 2021 Feb; 149():105235. PubMed ID: 33383186
[TBL] [Abstract][Full Text] [Related]
5. Adult neural function requires MeCP2.
McGraw CM; Samaco RC; Zoghbi HY
Science; 2011 Jul; 333(6039):186. PubMed ID: 21636743
[TBL] [Abstract][Full Text] [Related]
6. Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome.
Moretti P; Levenson JM; Battaglia F; Atkinson R; Teague R; Antalffy B; Armstrong D; Arancio O; Sweatt JD; Zoghbi HY
J Neurosci; 2006 Jan; 26(1):319-27. PubMed ID: 16399702
[TBL] [Abstract][Full Text] [Related]
7. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
8. Rett syndrome: a complex disorder with simple roots.
Lyst MJ; Bird A
Nat Rev Genet; 2015 May; 16(5):261-75. PubMed ID: 25732612
[TBL] [Abstract][Full Text] [Related]
9. Rescue of behavioral and EEG deficits in male and female Mecp2-deficient mice by delayed Mecp2 gene reactivation.
Lang M; Wither RG; Colic S; Wu C; Monnier PP; Bardakjian BL; Zhang L; Eubanks JH
Hum Mol Genet; 2014 Jan; 23(2):303-18. PubMed ID: 24009314
[TBL] [Abstract][Full Text] [Related]
10. Radically truncated MeCP2 rescues Rett syndrome-like neurological defects.
Tillotson R; Selfridge J; Koerner MV; Gadalla KKE; Guy J; De Sousa D; Hector RD; Cobb SR; Bird A
Nature; 2017 Oct; 550(7676):398-401. PubMed ID: 29019980
[TBL] [Abstract][Full Text] [Related]
11. Unconventional transcriptional response to environmental enrichment in a mouse model of Rett syndrome.
Kerr B; Silva PA; Walz K; Young JI
PLoS One; 2010 Jul; 5(7):e11534. PubMed ID: 20634955
[TBL] [Abstract][Full Text] [Related]
12. The relationship of Rett syndrome and MECP2 disorders to autism.
Neul JL
Dialogues Clin Neurosci; 2012 Sep; 14(3):253-62. PubMed ID: 23226951
[TBL] [Abstract][Full Text] [Related]
13. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
14. Rett syndrome: from bed to bench.
Weng SM; Bailey ME; Cobb SR
Pediatr Neonatol; 2011 Dec; 52(6):309-16. PubMed ID: 22192257
[TBL] [Abstract][Full Text] [Related]
15. Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome.
Garg SK; Lioy DT; Cheval H; McGann JC; Bissonnette JM; Murtha MJ; Foust KD; Kaspar BK; Bird A; Mandel G
J Neurosci; 2013 Aug; 33(34):13612-20. PubMed ID: 23966684
[TBL] [Abstract][Full Text] [Related]
16. Reversal of neurological defects in a mouse model of Rett syndrome.
Guy J; Gan J; Selfridge J; Cobb S; Bird A
Science; 2007 Feb; 315(5815):1143-7. PubMed ID: 17289941
[TBL] [Abstract][Full Text] [Related]
17. Neuronal morphology in MeCP2 mouse models is intrinsically variable and depends on age, cell type, and Mecp2 mutation.
Wang IT; Reyes AR; Zhou Z
Neurobiol Dis; 2013 Oct; 58():3-12. PubMed ID: 23659895
[TBL] [Abstract][Full Text] [Related]
18. Cellular origins of auditory event-related potential deficits in Rett syndrome.
Goffin D; Brodkin ES; Blendy JA; Siegel SJ; Zhou Z
Nat Neurosci; 2014 Jun; 17(6):804-6. PubMed ID: 24777420
[TBL] [Abstract][Full Text] [Related]
19. Synaptic plasticity deficits in an experimental model of rett syndrome: long-term potentiation saturation and its pharmacological reversal.
Weng SM; McLeod F; Bailey ME; Cobb SR
Neuroscience; 2011 Apr; 180():314-21. PubMed ID: 21296130
[TBL] [Abstract][Full Text] [Related]
20. Profiling beneficial and potential adverse effects of MeCP2 overexpression in a hypomorphic Rett syndrome mouse model.
Vermudez SAD; Gogliotti RG; Arthur B; Buch A; Morales C; Moxley Y; Rajpal H; Conn PJ; Niswender CM
Genes Brain Behav; 2022 Jan; 21(1):e12752. PubMed ID: 34002468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
